Generics
Partner
Company
News
Contact

Select Page

Amring Pharmaceuticals Inc. issues nationwide Class III recall for 2 lots of Tranexamic Acid Tablets

by Will Figueiredo | Jun 13, 2023 | News

June 12, 2023

Search for:

Recent Posts

Amring Pharmaceuticals Inc. issues nationwide Class III recall for 2 lots of Tranexamic Acid Tablets
Amring Pharmaceuticals Inc. Joins End Drug Shortages Alliance
Amring Pharmaceuticals Inc. Announces the Launch of Timolol Maleate Ophthalmic Solution, USP 0.5%
Amring Pharmaceuticals Inc. Announces the Approval and Launch of Generic Lamotrigine Orally Disintegrating Tablets (ODT), USP
Amzell B.V. and Amring Pharmaceuticals Inc. Attending 2021 American Epilepsy Society Meeting

Recent Comments

Archives

June 2023
July 2022
June 2022
February 2022
December 2021
November 2021
October 2021
August 2021
March 2021
December 2020
August 2020
June 2019
January 2019
July 2018
June 2017
March 2017
April 2016
March 2016
January 2016
December 2015
June 2015

Categories

News
Uncategorized

Meta

Log in
Entries feed
Comments feed
WordPress.org

Get in touch

Phone: 844.304.4828 More contact options

Get to know Amring

Products Partner Company LinkedIn

What’s new

Amring Pharmaceuticals Inc. announced that it has received FDA approval for generic Timolol Maleate Ophthalmic Solution, USP 0.5%, 60 pack of 0.3mL unit dose vials (AT3 rated generic equivalent of Timoptic® in Ocudose®) and has begun commercialization activities.

More news & events